BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 28678401)

  • 21. The fanconi anemia pathway limits human papillomavirus replication.
    Hoskins EE; Morreale RJ; Werner SP; Higginbotham JM; Laimins LA; Lambert PF; Brown DR; Gillison ML; Nuovo GJ; Witte DP; Kim MO; Davies SM; Mehta PA; Butsch Kovacic M; Wikenheiser-Brokamp KA; Wells SI
    J Virol; 2012 Aug; 86(15):8131-8. PubMed ID: 22623785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fanconi anaemia and cancer: an intricate relationship.
    Nalepa G; Clapp DW
    Nat Rev Cancer; 2018 Mar; 18(3):168-185. PubMed ID: 29376519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of mutations in FANCL gene: a second case of Fanconi anemia belonging to FA-L complementation group.
    Ali AM; Kirby M; Jansen M; Lach FP; Schulte J; Singh TR; Batish SD; Auerbach AD; Williams DA; Meetei AR
    Hum Mutat; 2009 Jul; 30(7):E761-70. PubMed ID: 19405097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.
    Gallmeier E; Hucl T; Calhoun ES; Cunningham SC; Bunz F; Brody JR; Kern SE
    Cancer Biol Ther; 2007 May; 6(5):654-60. PubMed ID: 17387268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.
    Taniguchi T; D'Andrea AD
    Blood; 2002 Oct; 100(7):2457-62. PubMed ID: 12239156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A requirement of FancL and FancD2 monoubiquitination in DNA repair.
    Seki S; Ohzeki M; Uchida A; Hirano S; Matsushita N; Kitao H; Oda T; Yamashita T; Kashihara N; Tsubahara A; Takata M; Ishiai M
    Genes Cells; 2007 Mar; 12(3):299-310. PubMed ID: 17352736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel homozygous FANCL mutation and somatic heterozygous SETBP1 mutation in a Chinese girl with Fanconi Anemia.
    Wu W; Liu Y; Zhou Q; Wang Q; Luo F; Xu Z; Geng Q; Li P; Zhang HZ; Xie J
    Eur J Med Genet; 2017 Jul; 60(7):369-373. PubMed ID: 28419882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for subcomplexes in the Fanconi anemia pathway.
    Medhurst AL; Laghmani el H; Steltenpool J; Ferrer M; Fontaine C; de Groot J; Rooimans MA; Scheper RJ; Meetei AR; Wang W; Joenje H; de Winter JP
    Blood; 2006 Sep; 108(6):2072-80. PubMed ID: 16720839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational and Functional Analysis of
    Glaas MF; Wiek C; Wolter LM; Roellecke K; Balz V; Okpanyi V; Wagenmann M; Hoffmann TK; Grässlin R; Plettenberg C; Schipper J; Hanenberg H; Scheckenbach K
    Anticancer Res; 2018 Mar; 38(3):1317-1325. PubMed ID: 29491055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generating New FANCA-Deficient HNSCC Cell Lines by Genomic Editing Recapitulates the Cellular Phenotypes of Fanconi Anemia.
    Errazquin R; Sieiro E; Moreno P; Ramirez MJ; Lorz C; Peral J; Ortiz J; Casado JA; Roman-Rodriguez FJ; Hanenberg H; Río P; Surralles J; Segrelles C; Garcia-Escudero R
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway.
    Sims AE; Spiteri E; Sims RJ; Arita AG; Lach FP; Landers T; Wurm M; Freund M; Neveling K; Hanenberg H; Auerbach AD; Huang TT
    Nat Struct Mol Biol; 2007 Jun; 14(6):564-7. PubMed ID: 17460694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
    Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
    Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic subtyping of Fanconi anemia by comprehensive mutation screening.
    Ameziane N; Errami A; Léveillé F; Fontaine C; de Vries Y; van Spaendonk RM; de Winter JP; Pals G; Joenje H
    Hum Mutat; 2008 Jan; 29(1):159-66. PubMed ID: 17924555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
    Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
    Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global and disease-associated genetic variation in the human Fanconi anemia gene family.
    Rogers KJ; Fu W; Akey JM; Monnat RJ
    Hum Mol Genet; 2014 Dec; 23(25):6815-25. PubMed ID: 25104853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of the tumor suppressor genes causing the hereditary syndromes predisposing to head and neck cancer via promoter hypermethylation in sporadic head and neck cancers.
    Smith IM; Mithani SK; Mydlarz WK; Chang SS; Califano JA
    ORL J Otorhinolaryngol Relat Spec; 2010; 72(1):44-50. PubMed ID: 20332657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional analysis of Fanconi anemia mutations in China.
    Li N; Ding L; Li B; Wang J; D'Andrea AD; Chen J
    Exp Hematol; 2018 Oct; 66():32-41.e8. PubMed ID: 30031030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M.
    Meetei AR; Medhurst AL; Ling C; Xue Y; Singh TR; Bier P; Steltenpool J; Stone S; Dokal I; Mathew CG; Hoatlin M; Joenje H; de Winter JP; Wang W
    Nat Genet; 2005 Sep; 37(9):958-63. PubMed ID: 16116422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.